• 1
    Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lowered complement levels. Clin Exp Immunol 1970; 6: 689706.
  • 2
    Harris ED Jr. Pathogenesis of rheumatoid arthritis. Am J Med 1986; 80: 410.
  • 3
    Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumor necrosis factor α production by adhered human monocytes: a key role for Fcγ receptor type IIIA in rheumatoid arthritis. Arthritis Rheum 2000; 43: 60816.
  • 4
    Marsh CB, Wewers MD, Tan LC, Rovin BH. Fcγ receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte FcγRIII. J Immunol 1997; 158: 107884.
  • 5
    Khalkhali-Ellis Z, Bulla GA, Schlesinger LS, Kirschmann DA, Moore TL, Hendrix MJ. C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors. J Immunol 1999; 163: 461220.
  • 6
    Jarvis JN, Wang W, Moore HT, Zhao L, Xu C. In vitro induction of proinflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes [published erratum appears in Arthritis Rheum 1998;41:377]. Arthritis Rheum 1997; 40: 203946.
  • 7
    Gallin JI. Inflammation. In: PaulWE, editor. Fundamental immunology. 3rd ed. New York: Raven Press; 1993.
  • 8
    Ravetch JV, Kinet JP. Fc receptors [review]. Annu Rev Immunol 1991; 9: 45792.
  • 9
    Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, Renardel de Lavalette C, Schmidt RE, et al. Murine IgG1 complexes trigger immune effector functions predominantly via Fcγ RIII (CD16). J Immunol 1998; 161: 302632.
  • 10
    Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics [review]. Crit Rev Immunol 2003; 23: 199250.
  • 11
    Kaplan CD, O'Neill SK, Koreny T, Czipri M, Finnegan A. Development of inflammation in proteoglycan-induced arthritis is dependent on FcγR regulation of the cytokine/chemokine environment. J Immunol 2002; 169: 58519.
  • 12
    Blom AB, van Lent PL, van Vuuren H, Holthuysen AE, Jacobs C, van de Putte LB, et al. FcγR expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res 2000; 2: 489503.
  • 13
    Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J Exp Med 2000; 191: 16116.
  • 14
    Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, et al. Arthritis critically dependent on innate immune system players. Immunity 2002; 16: 15768.
  • 15
    Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J Immunol 2003; 170: 431824.
  • 16
    Van Lent PL, van Vuuren AJ, Blom AB, Holthuysen AE, van de Putte LB, van de Winkel JG, et al. Role of Fc receptor γ chain in inflammation and cartilage damage during experimental antigen-induced arthritis. Arthritis Rheum 2000; 43: 74052.
  • 17
    Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, et al. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002; 16: 391402.
  • 18
    Nabbe KC, Blom AB, Holthuysen AE, Boross P, Roth J, Verbeek S, et al. Coordinate expression of activating Fcγ receptors I and III and inhibiting Fcγ receptor type II in the determination of joint inflammation and cartilage destruction during immune complex–mediated arthritis. Arthritis Rheum 2003; 48: 25565.
  • 19
    Diaz de Stahl T, Andren M, Martinsson P, Verbeek JS, Kleinau S. Expression of FcγRIII is required for development of collagen-induced arthritis. Eur J Immunol 2002; 32: 291522.
  • 20
    Finnegan A, Mikecz K, Tao P, Glant TT. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol 1999; 163: 538390.
  • 21
    Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002; 169: 334552.
  • 22
    Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, Park LS, et al. Lymphokine control of in vivo immunoglobulin isotype selection [review]. Annu Rev Immunol 1990; 8: 30333.
  • 23
    Kaplan C, Valdez JC, Chandrasekaran R, Eibel H, Mikecz K, Glant TT, et al. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res 2002; 4: 548.
  • 24
    Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum 1987; 30: 20112.
  • 25
    Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 1996; 5: 1818.
  • 26
    Bardos T, Mikecz K, Finnegan A, Zhang J, Glant TT. T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system. J Immunol 2002; 168: 601321.
  • 27
    Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors [review]. Annu Rev Immunol 2000; 18: 70937.
  • 28
    Ravetch JV, Bolland S. IgG Fc receptors [review]. Annu Rev Immunol 2001; 19: 27590.
  • 29
    Mikecz K, Glant TT. Immunoregulation of proteoglycan-induced arthritis in Balb/c mice. Am J Ther 1996; 3: 4251.
  • 30
    Buzas EI, Mikecz K, Brennan FR, Glant TT. Mediators and autopathogenic effector cells in proteoglycan-induced arthritic and clinically asymptomatic BALB/c mice. Cell Immunol 1994; 158: 292304.
  • 31
    Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 2002; 16: 37989.
  • 32
    Dhodapkar KM, Krasovsky J, Williamson B, Dhodapkar MV. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J Exp Med 2002; 195: 12533.
  • 33
    Reijonen H, Novak EJ, Kochik S, Heninger A, Liu AW, Kwok WW, et al. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002; 51: 137582.
  • 34
    Rafiq K, Bergtold A, Clynes R. Immune complex-mediated antigen presentation induces tumor immunity. J Clin Invest 2002; 110: 719.
  • 35
    Hamano Y, Arase H, Saisho H, Saito T. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol 2000; 164: 61139.